How Biotechgate Uses Artificial Intelligence

At Biotechgate, we provide you with a comprehensive life sciences database, allowing users access to up-to-date information covering companies, licensing deals, financing rounds and more. We use a unique data-sourcing process to gather large amounts of information across the entire biopharma industry, giving Biotechgate users access to unprecedented information – thanks, in part, to artificial … Continue reading How Biotechgate Uses Artificial Intelligence

Read more

The Current State of M&A Activity in the Life Sciences Industry

The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the … Continue reading The Current State of M&A Activity in the Life Sciences Industry

Read more

Life Sciences M&A Report: Half-Year 2023

In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023

Read more

Introducing M&A deals to Biotechgate

Biotechgate is continuously working on enhancements and new tools to boost the experience for our users. Currently, Biotechgate is developing a new release, which is planned for early 2024: Among the various new features that subscribers can look forward to, one in particular worth highlighting revolves around M&A deals and is unique on the market … Continue reading Introducing M&A deals to Biotechgate

Read more

Interoperability in Digital Health: Driving Innovation for Better Patient Care

Data interoperability in the digital health industry is more than just a buzzword: It stands for the potential to transform the way healthcare providers exchange electronic patient data. In this article, we will explore the importance of interoperability and the challenges it faces. Find out how to discover companies in Biotechgate that lead the development … Continue reading Interoperability in Digital Health: Driving Innovation for Better Patient Care

Read more

Financing in Digital Health: An Overview

Digital health is an industry in the life sciences experiencing constant innovation as well as attention from both investors and fellow companies. The Biotechgate Business Development Database contains an array of up-to-date information on digital health. In this article, you’ll find an overview of how funding in the industry has developed and further analysis of … Continue reading Financing in Digital Health: An Overview

Read more

Digital Health Categorization in Biotechgate Explained

Previously referred to as HealthTech, the digital health category is one of the six core company sectors in the Biotechgate database. Read our brief overview on what exactly this area consists of and how we define companies that fall under the digital health umbrella. The digital health sector does not always fit into the common … Continue reading Digital Health Categorization in Biotechgate Explained

Read more

Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation

Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub … Continue reading Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation

Read more

Norway Life Science Trend Analysis 2023

The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023

Read more

The Top 5 Biggest Licensing Deals of 2023 So Far

As biotechs face a challenging commercial environment with limited options for IPOs, interest in forging partnership agreements remains high. This article explores five top biotech and pharma licensing deals, ranked by the potential total deal value, that 2023 has brought to date. From advancing precision oncology to regenerative medicine, these partnerships underscore a commitment to … Continue reading The Top 5 Biggest Licensing Deals of 2023 So Far

Read more